Searched for
TACROLIMUS
Dr Reddy's Lab recalls over 4,000 bottles of generic drug in USNew Jersey-based Dr Reddy's Laboratories Inc, a unit of the company, is recalling the affected lot due to "Presence of one Tacrolimus 1 mg ...07 Mar, 2023, 05.13 PM IST- Concord Biotech files DRHP with Sebi for Rs 2,000-2,500 cr IPOSources told ET that the IPO would be of ₹2000 crore - ₹2500 crore size.The issue with a face value of ₹1 per equity share is a complete of...16 Aug, 2022, 04.14 PM IST
- Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with SebiAs per an F&S report, Concord Biotech commands a market share of over 20 per cent by volume in 2021 across identified fermentation-based AP...16 Aug, 2022, 03.39 PM IST
- Manufacturing issues led drug makers Glenmark, Sun Pharma, Dr Reddy's to recall products in USAs per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may caus...14 Aug, 2022, 01.09 PM IST
- Panacea Biotec sells domestic formulation assets to Mankind Pharma for Rs 1,908 crorePanacea said it expects to complete the transaction by the end of this year.01 Feb, 2022, 06.55 PM IST
- Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics“2020 has been one of the most challenging years for the world with an unprecedented pandemic impact on the global economy. We continue to ...22 Jan, 2021, 08.59 AM IST
- Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in USThe drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 4...10 Jan, 2021, 12.15 PM IST
- Lupin, Concord Biotech get USFDA nod for generic immunosuppressant capsulesIn alliance with Concord Biotech, the company has received approval from the United States Food and Drug Administration (USFDA) to market T...12 Nov, 2020, 05.19 PM IST
- Glenmark Pharma gets USFDA nod for Tacrolimus capsulesGlenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus...11 Nov, 2020, 11.21 AM IST
- Panacea Biotec enters collaboration with Bionpharma for generics worth $800 millionShare prices spiked upon the development, going as high as 9.75% (Rs 148 a piece) on the Bombay Stock Exchange before 11:00 am on Friday.28 Jul, 2017, 12.45 PM IST
- Strides Arcolab gets USFDA approval for Tacrolimus capsulesThe product will be manufactured at the company's oral dosage facility at Bangalore and marketed directly by Strides in the US market.23 Jul, 2014, 06.57 PM IST
- Strides Arcolab gets USFDA approval to sell transplant drugThe capsule is an immuno-suppressant used for preventing organ rejection in certain patients following liver, kidney, or heart transplant.23 Jul, 2014, 02.36 PM IST
- Panacea Biotech enters into pact with Kremers Urban; stock upShares of Panacea Biotech gained momentum after the company entered into strategic alliance with Kremers Urban for 11 high barrier to entry...19 Nov, 2012, 02.01 PM IST
- Dr Reddy's expects North American biz to drive growth this FYDr Reddy's Laboratories expects generics business in North America to be its main growth driver this fiscal.07 Aug, 2011, 11.02 AM IST
- Dr Reddy's Laboratories' revenues in Q1 grew by 18% to 1,970 crPharma major Dr Reddy's Laboratories' revenues in the first quarter grew by 18% to 1,970 crore compared to the corresponding period.21 Jul, 2011, 04.37 AM IST
- Astellas aims to emerge top player in transplantationJapan’s second-largest pharma company, the $10-billion Astellas Pharma, intends to emerge as a niche player in India.10 May, 2010, 02.15 AM IST
- Citigroup assigns 'sell' on BioconForeign brokerage Citigroup has assigned a ‘sell’ rating on integrated biotechnology company Biocon citing higher vulnerability of the comp...19 Aug, 2009, 02.27 AM IST
Load More
